Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.


TSX:CPH - Post by User

Bullboard Posts
Post by 0buylowsellhighon Oct 16, 2015 10:37am
105 Views
Post# 24197579

CPH Decline

CPH DeclineNeed fresh news. The decline will continue as retail investors have been burnt and commercial investors are simply not interested. The low volumes speak loudly. The momentum is slow but it is surely to the downside. CPH only saw some relief on "news" of the patent suit. I have not and will not even consider it a useable short as the marketplace has better prospects including some longs. I can see $3.00 as a strong probability in the next coming months. Those that feel "fraud" occurred then let management know and call the securities office of the TSX and launch a suit accordingly. Anything else is mute and no repetitive posting of such alleged illegal activity does not support one iota the position of such. Happy$$$Hunting!!!
Bullboard Posts